Radiolabeling
Radiolabeling — The incorporation of a radioactive isotope into a peptide for tracking distribution, metabolism, or receptor binding in biological systems.
What Is Radiolabeling?
Radiolabeling is the incorporation of a radioactive isotope into a peptide for tracking, imaging, quantification, or therapy. Radiolabeled peptides enable ultrasensitive detection (femtomolar), whole-body biodistribution imaging, receptor quantification, and targeted radionuclide therapy of cancer.
Common Radioisotopes for Peptides
- ³H (tritium): Beta emitter. t1/2 = 12.3 years. Radioligand binding assays
- ¹²⁵I: Gamma emitter. t1/2 = 60 days. Tyr iodination for binding assays
- ⁶⁸Ga: Positron emitter. t1/2 = 68 min. PET imaging with DOTA-peptide conjugates
- ¹⁷⁷Lu: Beta/gamma. t1/2 = 6.7 days. Peptide receptor radionuclide therapy (PRRT)
Frequently Asked Questions
What is Radiolabeling?
The incorporation of a radioactive isotope into a peptide for tracking distribution, metabolism, or receptor binding in biological systems.
Why is Radiolabeling important in peptide research?
Radiolabeling is a fundamental concept in analytical as it relates to peptide science. It directly influences experimental design, compound characterization, and the reliability of research outcomes across biochemistry and molecular biology disciplines.